Barinthus Biotherapeutics (BRNS) Shares Issued (2021 - 2023)
Barinthus Biotherapeutics' (BRNS) quarterly Shares Issued came in at $6.4 million in Q3 2023, up 28.45% YoY from $5.0 million in Q3 2022, and down 5.74% on a QoQ basis from $6.8 million in Q2 2023.
Barinthus Biotherapeutics (BRNS) Shares Issued (2021 - 2023) Analysis & Trends
Barinthus Biotherapeutics (BRNS) has 3 years of Shares Issued data on file, last reported at $6.4 million in Q3 2023.
- Quarterly Shares Issued rose 28.45% year-over-year to $6.4 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $6.4 million (up 28.45% YoY) and the FY2022 annual result came in at $1.5 million, up 85.62% from the prior year.
- Shares Issued eased to $6.4 million in Q3 2023, from $6.8 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $6.8 million in Q1 2023 to a low of $795650.0 in Q4 2021.
- A 3-year average of $4.1 million and a median of $4.8 million in 2022 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2022 — Shares Issued soared 154.03% — and 2023, when it increased 28.45%.
- Tracing BRNS's Shares Issued over 3 years: stood at $795650.0 in 2021, then soared by 85.62% to $1.5 million in 2022, then surged by 332.78% to $6.4 million in 2023.
- The last three Shares Issued figures came in at $6.4 million (Q3 2023), $6.8 million (Q2 2023), and $6.8 million (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 25.40 Mn | 25.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 6.39 Mn |
| Sep 30, 2023 | 6.39 Mn |
| Jun 30, 2023 | 6.78 Mn |
| Jun 30, 2023 | 6.78 Mn |
| Mar 31, 2023 | 6.81 Mn |
| Mar 31, 2023 | 6.81 Mn |
| Dec 31, 2022 | 1.48 Mn |
| Dec 31, 2022 | 1.48 Mn |
| Sep 30, 2022 | 4.98 Mn |
| Sep 30, 2022 | 4.98 Mn |
| Jun 30, 2022 | 4.94 Mn |
| Jun 30, 2022 | 4.94 Mn |
| Mar 31, 2022 | 4.81 Mn |
| Mar 31, 2022 | 4.81 Mn |
| Dec 31, 2021 | 795,650.00 |
| Dec 31, 2021 | 795,650.00 |
| Sep 30, 2021 | 3.36 Mn |
| Sep 30, 2021 | 3.36 Mn |
| Jun 30, 2021 | 3.41 Mn |
| Jun 30, 2021 | 3.41 Mn |